Acetylsalicylic acid Completed Phase 2 Trials for Acute Respiratory Distress Syndrome (ARDS) Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01504867LIPS-A: Lung Injury Prevention Study With Aspirin